Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Buying has completely dried up.
Low volume selling means gains will have to be re-earned.
This is a complete reset of the price, and it’s utter bullshit. Once again, a company’s inability to come even close to their estimates destroys shareholder value.
Buffet’s 10% gains dwarf the entirety of iHub.
He can be more patient for more total gain than most.
What I think this does is cement the trading style I’ve been shifting to: never ever hold for any story or expectation ever.
You get 15%? Take it ruthlessly and wait for a heavy sell off to do it again.
Unfortunately the market has devolved into swing traders and manipulation. There is no real investment outside of multi-year gains, and even then you sacrifice obvious sell points.
I’ll stay in this one through the end of the year, but this’ll probably be the last story hold I’ll do.
Also potential EUA.
I’m holding through EOY. If they can’t get it done by then, it’s time to move on.
Others will hold for the next year minimum. Not a bad idea to get long term taxes.
Looks like a decent amount relative to average volume, but nothing earth-shattering.
I expect the trend will have heavily increased for the last two weeks given the heavy price drop the last few trading days.
Yes.
There isn’t a “standard time” when releases go out; I suppose it’s more likely that it’d be in the afternoon; at least that’s what I’ve observed thus far.
I apologize to you on behalf of the board for not giving you an answer in a timely fashion. We’ll strive in the future to be more accommodating to your needs.
I'll reiterate and elaborate:
If you believe that IR is lying, then you must sell. Anything else is insanity.
If you don't actually believe that IR is lying, but your (and my) expectations were wildly out of proportion with reality, then you hold and deal with being down.
That's a broad difference. I think PR is putting spin on the truth, but I don't think the enrollment is failing drastically. I also adjusted my expectations of getting data until after the election and a hold period through the end of the year.
If you believe that, you have to sell.
If true, the stock will tank extremely hard.
If you don’t actually believe that, then don’t claim IR is lying because your perception didn’t line up with reality. We’re all in a similar position, and it’s gut check time.
Going as expected per THEIR expectations.
I’m sure they have quite a bit of data and projections were not updated on.
That’s the life of an investor lol
I actually have a urban dictionary reference named after me.
https://www.google.com/amp/s/www.urbandictionary.com/define.php%3Fterm%3DPostlewait%2520Effect%26amp%3Dtrue
Don’t worry, I moved all my cash into GME and HGEN, so of course they both drop about 15% immediately after, lol.
Will have to check shorting numbers for this period when they become available. Certainly feels forced, but speculators are probably upset phase 3 data hasn’t arrived.
Company is responsible for the expectations.
That’s a second-order event. The market responds slowly.
Yeah, trading on the edges can be rough.
Unfortunately true in the short term.
Only major news stops the bleeding back to 10s; long term still fine.
Piggyback registration also means that the shares that investors purchase can be registered as unrestricted at the same time as shares offered by the underwriters.
It’ll be interesting to see the short numbers by January.
Holiday season is going to put continued pressure on them to cover.
Sure hope so. People are gonna get nervous the farther away we get from October with no Phase 3 update.
It’s unfortunate, but it does appear that HGEN’s timeline is about 2-3 months further left than expected.
Of Phase 3 data isn’t out in early November, people are going to panic.
Def miscalculated the general price movement. I expected $15 into January, not now. Sheesh
I’ve got about 20k left I’m trying to move. Hopefully I can do it over next week.
I’d like to be roughly 50/50 between them; I’d like to see at least one pop off by eoy.
Yep. I was able to free up an additional 8 grand and just threw it on 15.
I want a piece through the Holiday season!
According to their own definition, the last posted date is the last time clinicaltrials has been updated, and they go on to specifically state that it’s not necessarily the most recent info.
You can click the info icon to get an explanation of “Last Update Posted”.
It says it was last updated August 5th.
Is there any reason to believe it’s been updated more recently than the last posted date?
If tomorrow you told me HGEN was getting bought out at $45 a share, and therefore the price matched sentiment to around $35 on heavy volume, I would sell in a heartbeat.
It's not the BOOM we want, but I'll take the guaranteed 3.5x (for me anyway) and not risk getting trapped in buyout limbo.
For others, it might be worth holding another year or so and maximizing the ceiling if the investment is significant and unneeded.
Something has to give at some point.
Any time a stock like this is suddenly down 6-7 percent, just buy.
The manipulation is ridiculous.
Don’t set stop losses in daily volatile stocks; it makes it so easy for small volume sells to wipe you out.
Damn, I’m happy for them, but it’s a bit of a dagger to the heart, lol
Bro...let it go. It’s revoked. It’s gone.
The ownership stole money and ghosted.
Just another OTC scam.
Foiled again!
HGEN slightly trailing GME.
Close race!
The overall trend is positive; I’m just whining.
The selling is absolutely infuriating.
I want to choke each and every person/entity that dumps for no reason.
I just sent a strongly worded email to Ealixir.
I’m sure they’ll respond right away...lol.
Eh, it’s by a hair, but point made.
I highly suspect that's the case.
If so, this is bigger than anyone imagined, and GILD should be STRONGLY considering a buyout if they want to be the market leader in COVID therapeutics.
Hell, that doesn't even consider the cancer angle at all.
It'll be very interesting to see how this impacts the BET.